Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
8 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Design of Arylsulfonylhydrazones as Potential FabH Inhibitors: Synthesis, Antimicrobial Evaluation and Molecular Docking.
Med Chem. 2021;17(5):474-484. doi: 10.2174/1573406415666191122111228.
Med Chem. 2021.
PMID: 31763975
New antibacterial agents: Hybrid bioisoster derivatives as potential E. coli FabH inhibitors.
Segretti ND, Serafim RA, Segretti MC, Miyata M, Coelho FR, Augusto O, Ferreira EI.
Segretti ND, et al.
Bioorg Med Chem Lett. 2016 Aug 15;26(16):3988-93. doi: 10.1016/j.bmcl.2016.06.089. Epub 2016 Jun 30.
Bioorg Med Chem Lett. 2016.
PMID: 27426865
Item in Clipboard
Discovery of ACH-000143: A Novel Potent and Peripherally Preferred Melatonin Receptor Agonist that Reduces Liver Triglycerides and Steatosis in Diet-Induced Obese Rats.
Ferreira MA Jr, Azevedo H, Mascarello A, Segretti ND, Russo E, Russo V, Guimarães CRW.
Ferreira MA Jr, et al. Among authors: segretti nd.
J Med Chem. 2021 Feb 25;64(4):1904-1929. doi: 10.1021/acs.jmedchem.0c00627. Epub 2021 Feb 8.
J Med Chem. 2021.
PMID: 33626870
Free article.
Item in Clipboard
Discovery of novel benzothiophene derivatives as potent and narrow spectrum inhibitors of DYRK1A and DYRK1B.
Segretti ND, Takarada JE, Ferreira MA Jr, da Silva Santiago A, Teodoro BVM, Damião MCFCB, Godoi PH, Cunha MR, Fala AM, Ramos PZ, Ishikawa EE, Mascarello A, Serafim RAM, Azevedo H, Guimarães CRW, Couñago RM.
Segretti ND, et al.
Bioorg Med Chem Lett. 2022 Jul 15;68:128764. doi: 10.1016/j.bmcl.2022.128764. Epub 2022 May 2.
Bioorg Med Chem Lett. 2022.
PMID: 35504513
Item in Clipboard
New tuberculostatic agents targeting nucleic acid biosynthesis: drug design using QSAR approaches.
Bueno RV, Braga RC, Segretti ND, Ferreira EI, Trossini GH, Andrade CH.
Bueno RV, et al. Among authors: segretti nd.
Curr Pharm Des. 2014;20(27):4474-85. doi: 10.2174/1381612819666131118170238.
Curr Pharm Des. 2014.
PMID: 24245758
Review.
Item in Clipboard
Medicinal Chemistry of New Compounds to Treat Tuberculosis.
Primi MC, Segretti ND, Ferreira EI.
Primi MC, et al. Among authors: segretti nd.
Curr Clin Pharmacol. 2015;10(2):139-159. doi: 10.2174/1574884708666131229125103.
Curr Clin Pharmacol. 2015.
PMID: 24433443
Item in Clipboard
Antimycobacterial activity of pyrazinoate prodrugs in replicating and non-replicating Mycobacterium tuberculosis.
Segretti ND, Simões CK, Corrêa MF, Felli VMA, Miyata M, Cho SH, Franzblau SG, Fernandes JPDS.
Segretti ND, et al.
Tuberculosis (Edinb). 2016 Jul;99:11-16. doi: 10.1016/j.tube.2016.04.002. Epub 2016 Apr 9.
Tuberculosis (Edinb). 2016.
PMID: 27449999
Item in Clipboard
Exploring the dark side of tertiary and quaternary structure dynamics in MtbFBPaseII.
Greco GLC, Segretti N, Abad-Zapatero C, Movahedzadeh F, Hirata MH, Ferreira EI, Ferreira GM.
Greco GLC, et al.
J Biomol Struct Dyn. 2023 Oct 14:1-9. doi: 10.1080/07391102.2023.2270528. Online ahead of print.
J Biomol Struct Dyn. 2023.
PMID: 37837432
Item in Clipboard
Cite
Cite